Strategic Partnerships Viz.ai is expanding reach through a Johnson & Johnson collaboration to commercialize the Subdural Hemorrhage solution across US hospitals, and through a NRHA partnership to extend AI powered care coordination into rural networks. These alliances create immediate sales opportunities with large hospital systems and rural facilities seeking advanced AI detection and streamlined care pathways.

Reimbursement & Governance Viz.ai is CMS reimbursed for AI and has top scores in Security Privacy Governance and Regulatory Readiness & Algorithm Lifecycle Management, which reduces buyer risk and speeds procurement. This strengthens the case for multi site expansions, enterprise licenses, and ongoing governance tool adoption with new care pathways.

Market Credibility The Viz Platform is deployed across thousands of hospitals and has earned top rankings and industry awards, giving sales teams a credibility edge when pursuing large health systems and integrated delivery networks. Opportunity to upsell additional modules such as pulmonary and hemorrhage care across existing accounts.

Product Expansion The May 2026 launch of Viz Pulmonary Suite signals a clear growth vector and cross sell potential within current customers. Additional disease areas and multi pathway integrations present opportunities to bundle offerings and secure multi year licenses.

Scale-ready Offering Revenue scale and a mid sized team reflect a capable go to market with strong deployment capabilities. Position offerings as enterprise grade with implementation support, data integration services, and managed services to win multi hospital deals and partnerships with life sciences companies for data collaboration.